We will describe the characteristics and evolution of CD34+SCs/TCs in examples of this section, including systemic sclerosis (scleroderma) in fibrosing/sclerosing diseases, basophilic degeneration of the collagen and cutaneous myxoid cysts in metabolic and degenerative disorders of the dermal extracellular matrix. This evidence concerns the gene CD34 and scleroderma.